We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Lab M Launches NutriTone™

Read time: Less than a minute

Lab M has launched NutriTone™, a new brand of peptones that includes a range of premium, growth-tested peptones designed to be used in mammalian cell culture for vaccine production and biotechnology.

Not only are NutriTone™ peptones for mammalian cell culture subjected to Lab M’s usual rigorous quality control procedures, uniquely each batch is assayed for cell growth in defined culture conditions. This provides extra assurance about in-use performance, supporting the development of high-yielding, cost-efficient processes.

Widely used to replace or supplement amino acids, bovine serum or foetal calf serum in mammalian cell culture, peptones may often be observed to increase product yields and reduce manufacturing costs.

With supplies of TSE-free serum increasingly difficult and expensive to source, demand for consistent, high quality peptones is growing. As natural products, peptones are inherently variable and most grades are unsuitable for mammalian cell culture. Lab M’s NutriTone™ range adds further assurance to products that already have a long pedigree in mammalian cell culture.

Lab M has close to 30 years’ experience in supplying peptones for biotechnology applications, dating back to the establishment of the International Vaccine Bank for Foot and Mouth Disease at the Institute of Animal Health in Pirbright, UK in 1985. Today, peptones from Lab M are used in both mammalian cell culture and microbial fermentation for the production of a variety of biomaterials, including antibodies and vaccines.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.